Neighborhood Social Determinants of Triple Negative Breast Cancer

被引:44
|
作者
Hossain, Fokhrul [1 ]
Danos, Denise [1 ]
Prakash, Om [1 ]
Gilliland, Aubrey [2 ]
Ferguson, Tekeda F. [2 ]
Simonsen, Neal [3 ]
Leonardi, Claudia [2 ]
Yu, Qingzhao [2 ]
Wu, Xiao-Cheng [2 ]
Miele, Lucio [1 ]
Scribner, Richard [2 ]
机构
[1] Louisiana State Univ, Hlth Sci Ctr, Sch Med, New Orleans, LA 70112 USA
[2] Louisiana State Univ, Hlth Sci Ctr, Sch Publ Hlth, New Orleans, LA USA
[3] Louisiana State Univ, Hlth Sci Ctr, New Orleans, LA USA
来源
基金
美国国家卫生研究院;
关键词
racial disparity; triple negative breast cancer; SEER database; multi-level modeling; concentrated disadvantage; socioeconomic factors; AFRICAN-AMERICAN WOMEN; HEALTH DISPARITIES; SOCIOECONOMIC-STATUS; BUILT ENVIRONMENT; SURVIVAL; DIAGNOSIS; STAGE; RACE; MORTALITY; SUBTYPES;
D O I
10.3389/fpubh.2019.00018
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Triple Negative Breast Cancer (TNBC) is an aggressive, heterogeneous subtype of breast cancer, which is more frequently diagnosed in African American (AA) women than in European American (EA) women. The purpose of this study is to investigate the role of social determinants in racial disparities in TNBC. Data on Louisiana TNBC patients diagnosed in 2010-2012 were collected and geocoded to census tract of residence at diagnosis by the Louisiana Tumor Registry. Using multilevel statistical models, we analyzed the role of neighborhood concentrated disadvantage index (CDI), a robust measure of physical and social environment, in racial disparities in TNBC incidence, stage at diagnosis, and stage-specific survival for the study population. Controlling for age, we found that AA women had a 2.21 times the incidence of TNBC incidence compared to EA women. Interestingly, the incidence of TNBC was independent of neighborhood CDI and adjusting for neighborhood environment did not impact the observed racial disparity. AA women were more likely to be diagnosed at later stages and CDI was associated with more advanced stages of TNBC at diagnosis. CDI was also significantly associated with poorer stage-specific survival. Overall, our results suggest that neighborhood disadvantage contributes to racial disparities in stage at diagnosis and survival among TNBC patients, but not to disparities in incidence of the disease. Further research is needed to determine the mechanisms through which social determinants affect the promotion and progression of this disease and guide efforts to improve overall survival.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Triple-negative breast cancer
    Stockmans, Gert
    Deraedt, Karen
    Wildiers, Hans
    Moerman, Philippe
    Paridaens, Robert
    [J]. CURRENT OPINION IN ONCOLOGY, 2008, 20 (06) : 614 - 620
  • [22] MicroRNAs and Triple Negative Breast Cancer
    D'Ippolito, Elvira
    Iorio, Marilena V.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2013, 14 (11): : 22202 - 22220
  • [23] Triple-Negative Breast Cancer
    Foulkes, William D.
    Smith, Ian E.
    Reis-Filho, Jorge S.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (20): : 1938 - 1948
  • [24] Triple Negative Breast Cancer: A Review
    Mercado, Cecilia
    Cangiarella, Joan
    Guth, Amber A.
    [J]. CURRENT WOMENS HEALTH REVIEWS, 2009, 5 (03) : 149 - 156
  • [25] Disparities in triple negative breast cancer
    Newman, Lisa
    Mitchell, Edith
    [J]. JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2023, 115 (02) : S8 - S12
  • [26] Management of triple negative breast cancer
    Oakman, Catherine
    Viale, Giuseppe
    Di Leo, Angelo
    [J]. BREAST, 2010, 19 (05): : 312 - 321
  • [27] Triple-Negative Breast Cancer
    Quyen D. Chu
    King, Tari
    Hurd, Thelma
    [J]. INTERNATIONAL JOURNAL OF BREAST CANCER, 2012, 2012
  • [28] Triple-negative breast cancer
    Chacon, Reinaldo D.
    Costanzo, Maria V.
    [J]. BREAST CANCER RESEARCH, 2010, 12
  • [29] Characterization of Triple Negative Breast Cancer
    Heredia Martinez, Bernardo Enrique
    Gonzalez Fernandez, Hailyn
    [J]. FINLAY, 2020, 10 (03): : 259 - 268
  • [30] Therapies for triple negative breast cancer
    Andreopoulou, Eleni
    Schweber, Sarah J.
    Sparano, Joseph A.
    McDaid, Hayley M.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (07) : 983 - 998